Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)
This study has been completed.
Study NCT00038961   Information provided by Sanofi-Aventis
First Received: June 5, 2002   Last Updated: April 25, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Venous Thrombosis
Additional conditions recognized in this trial
Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Vascular Diseases
Interventions listed in this trial
Fondaparinux Sodium
Additional drug interventions recognized in this trial
Fondaparinux
Org 31540
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis
Organon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services